AHA Presents Up-To-Date Statistics for Cardiovascular Disease
19.05 million deaths estimated for CVD globally in 2020, representing an increase of 18.71 percent from 2010
Diagnosis & Disease Information
Intensive Blood Pressure Control May Delay Progression in Advanced CKD
Patients with advanced CKD have not been well-represented in trials evaluating intensive blood pressure control.
Nonsteroidal MRAs Reduce Kidney, Cardiovascular Risks
The systematic review and meta-analysis included a broad range of patients with and without chronic kidney disease.
Occurrence of Cardiovascular Events, Death Compared Between Thiazides
Occurrence of major cardiovascular events, non-cancer-related deaths no lower with chlorthalidone versus hydrochlorothiazide
High Coffee Intake Linked to CVD Mortality in Severe Hypertension
No association seen for people with optimal and normal BP, high-normal BP, grade 1 hypertension
Quinapril Tablets Recalled Due to Nitrosamine Impurity
Quinapril Tablet is indicated for the treatment of hypertension.
Resistant Hypertension Effectively Treated With Novel Drug
Blocking the endothelin pathway could represent a new mode of action to lower blood pressure in resistant hypertension, according to investigators.
November 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in November 2022 for investigational products in development.
Bromocriptine Quick Release Beneficial for Teens With T1DM
Improvements seen in blood pressure and central and peripheral aortic stiffness and pressure hemodynamics in teens with type 1 diabetes
Continuing ACE Inhibitors Despite Potassium Change Can Have Benefits
Stopping renin-angiotensin-aldosterone inhibitors after hyperkalemia may offset their potential clinical benefits, according to investigators.
